Drugs used in the treatment of CHF Flashcards
Positive inotropic drugs
Digitalis Glycosides
Beta-1 agonists
Types of Digitalis Glycosides
Digitoxin
Ouabain
Digoxin
MOA of Digoxin
Inhibition of Na+-K+ ATPase in the myocardial cell membrane increases Na+ available for exchange with Ca2+
The result is increase inintracellular Ca2+ which results in a positive inotropic effect
Cardiovascular effects of Digoxin
Positive inotrope
Reduction in sinus rate and slowing AV conduction
Prolonged PR intervals in ECG
Increased mechanical efficiency of the failing heart
Normalization of BP and peripheral resistance
Digoxin kidney and GI effects
Kidney = Diuretic effect mainly secondary to increased cardiac output GI = GI irritation, vomiting
Digoxin Pharmacokinetics
Administered orally and can be given by slow IV in an emergency
Oral bioavailability is more for the elixir than for the tablet
Half life depends on the species
Small amount metabolized by the liver
Undergoes hepatic recycling
Excretion is mainly renal in dogs and horses, and renal and hepatic in cats
Therapeutic uses of Digoxin
CHF
Atrial arrhythmias in dogs
Adverse effects of Digitalis Glycosides
Digitalis has a narrow safety margin Cats are more sensitive than dogs Tachyarrhythmias Bradyarrhythmias GI
Adverse effect of Digitalis Glycosides
-Tachyarrhythmias
Predisposing Factors - hypokalemia, hypomagnesemia, hypercalcemia, hypernatrmia, hypothyroidism, hypoxemia
Treatment - drug withdrawal, K+ IV, antiarrhythmic drugs, cholestgramine, Digoxine immuen Fab
Adverse effect of Digitalis Glycosides
-Bradyarrhythmias
Treatment - drug withdrawal, Atropine (drug of choice)
Adverse effect of Digitalis Glycosides
-GI
Clinical signs - anorexia, vomiting, diarrhea
Treatment - drug withdrawal, fluid therapy
Beta-1 agonist drugs and uses
Positive Inotropes
Only used in emergencies
Dopamine
Dobutamine
Inodilator drugs
Inamrinone
Milrinone
Pimobendan
MOA of Inodilators
In the failing heart, Pinobendanacts by sensitization of the cardiac contractile apparatus to Ca2+ by enhancing the interaction between Ca2+ and troponin C complex
Inhibits phosphodiesterase III and IV = potential to increase intracellular Ca2+ and increased myocardial O2 consumption; minimal effect at therapeutic doses in dogs with CHF
Inhibition of phosphodiesterase III and IV results in vasodilation in arteries and veins = reduction in both cardiac preload and afterload
Uses of Inodilators
Approved to treat CHF in dogs
Adjunctive therapy in improving the quality and length of life in dogs with heart failure due to both dilated cardiomyopathy and chronic degenerative valvular disease
Used with furosemide, spironolactone, or ACE in heart failure patients